Current and future use of nucleo(s)tide prodrugs in the treatment of hepatitis C virus infection

This review describes the current state of discovery of past most important nucleoside and nucleotide prodrugs in the treatment of hepatitis C virus infection as well as future potential drugs currently in discovery or clinical evaluation. I highlight first generation landmark prodrug compounds whic...

Descripción completa

Detalles Bibliográficos
Autor principal: Dousson, Cyril B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
SI: Advances in Antiviral Nucleoside Analogs and Their Prodrugs
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890546/
https://www.ncbi.nlm.nih.gov/pubmed/29463095
http://dx.doi.org/10.1177/2040206618756430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890546/
https://www.ncbi.nlm.nih.gov/pubmed/29463095
http://dx.doi.org/10.1177/2040206618756430

Ejemplares similares